Evidence map›Paper›PMID 38325896›Full record

Trial reportBMJ global health2024

Examining local smoke-free coalitions in Armenia and Georgia: context and outcomes of a matched-pairs community-randomised controlled trial.

Carla J Berg, Regine Haardörfer, Arevik Torosyan, Ana Dekanosidze, Lilit Grigoryan, Zhanna Sargsyan, Varduhi Hayrumyan, Lela Sturua, Marina Topuridze, Varduhi Petrosyan and 2 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03447912 (Smoke-free Air Coalitions in Georgia and Armenia), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03447912 nacompletednot on this map

Smoke-free Air Coalitions in Georgia and Armenia: A Community Randomized Trial

TypeinterventionalSponsorEmory UniversityRan2018 to 2022Enrolled2,924ConditionsSmokingArmsIntervention Condition
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carla J BergMilken Institute School of Public Health, The George Washington University, Washington, District of Columbia, USA carlaberg@gwu.edu.ORCID 0000-0001-8931-1961
Regine HaardörferRollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Arevik TorosyanNational Institute of Health Named After Academician Suren Avdalbekyan, Yerevan, Armenia.
Ana DekanosidzeNational Center for Disease Control and Public Health, Tbilisi, Georgia.
Lilit GrigoryanNational Institute of Health Named After Academician Suren Avdalbekyan, Yerevan, Armenia.
Zhanna SargsyanTurpanjian College of Health Sciences, American University of Armenia, Yerevan, Armenia.
Varduhi HayrumyanTurpanjian College of Health Sciences, American University of Armenia, Yerevan, Armenia.
Lela SturuaNational Center for Disease Control and Public Health, Tbilisi, Georgia.
Marina TopuridzeNational Center for Disease Control and Public Health, Tbilisi, Georgia.
Varduhi PetrosyanTurpanjian College of Health Sciences, American University of Armenia, Yerevan, Armenia.
Alexander BazarchyanNational Institute of Health Named After Academician Suren Avdalbekyan, Yerevan, Armenia.
Michelle C KeglerRollins School of Public Health, Emory University, Atlanta, Georgia, USA.

Funding

Recreational Marijuana Marketing and Young Adult Consumer Behavior - Administrative SupplementR01DA054751 · NIDA · GEORGE WASHINGTON UNIVERSITY · PI Carla J Berg, Patricia A Cavazos-Rehg · 2022 to 2026
$4.3M
Regulatory Impact on Vape Shops and Young Adults' Use of ENDS - Diversity SupplementR01CA215155 · NCI · GEORGE WASHINGTON UNIVERSITY · PI BERG, CARLA J · 2018 to 2022
$3.4M
Implementing a Scalable Smoke-free Home Intervention in Armenia and GeorgiaR01CA278229 · NCI · GEORGE WASHINGTON UNIVERSITY · PI Carla J Berg, MICHELLE C KEGLER · 2023 to 2026
$2.3M
Effects of State Preemption of Local Tobacco Control Legislation on Disparities in Tobacco Use, Exposure and RetailR01CA275066 · NCI · GEORGE WASHINGTON UNIVERSITY · PI Carla J Berg, Y. Tony Yang · 2023 to 2026
$2.0M
Smoke-free Air Coalitions in Georgia and Armenia: A Community Randomized TrialR01TW010664 · FIC · EMORY UNIVERSITY · PI BERG, CARLA J, KEGLER, MICHELLE C · 2017 to 2021
$1.5M
Emory-Georgia Clean Air Research & Education (CARE) ProgramD43ES030927 · NIEHS · EMORY UNIVERSITY · PI BERG, CARLA J, CAUDLE, WILLIAM MICHAEL · 2019 to 2025
$1.2M
Assessing IQOS Marketing Influences and Consumer Behavior in Israel: Implications for the USR01CA239178 · NCI · GEORGE WASHINGTON UNIVERSITY · PI BERG, CARLA J, LEVINE, HAGAI · 2019 to 2021
$1.2M
Armenia-US Collaboration to Address Chronic Disease via Education in Social Determinants Science (ACCESS)D43TW012456 · FIC · GEORGE WASHINGTON UNIVERSITY · PI Carla J Berg, Nino Paichadze · 2023 to 2026
$974k
An mHealth Positive Psychology Intervention to Reduce Cancer Burden in Young Adult Cancer SurvivorsR21CA261884 · NCI · GEORGE WASHINGTON UNIVERSITY · PI AREM, HANNAH, BERG, CARLA J · 2022 to 2023
$428k
FIC NIH HHS D43 TW012456FIC NIH HHS R01 TW010664NCI NIH HHS R01 CA215155NCI NIH HHS R01 CA239178NCI NIH HHS R01 CA275066NCI NIH HHS R01 CA278229NCI NIH HHS R21 CA261884NIDA NIH HHS R01 DA054751NIEHS NIH HHS D43 ES030927
6 · The paper itself

Abstract

introductionLocal coalitions can advance public health initiatives such as smoke-free air but have not been widely used or well-studied in low-income and middle-income countries.

methodsWe conducted a matched-pairs community-randomised controlled trial in 28 communities in Armenia and Georgia (N=14/country) in which we helped establish local coalitions in 2019 and provided training and technical assistance for coalition activity promoting smoke-free policy development and enforcement (2019-2021). Surveys of ~1450 households (Fall 2018, May-June 2022) were conducted to evaluate coalition impact on smoke-free policy support, smoke-free home adoption, secondhand smoke exposure (SHSe), and coalition awareness and activity exposure, using multivariable mixed modelling.

resultsBivariate analyses indicated that, at follow-up versus baseline, both conditions reported greater smoke-free home rates (53.6% vs 38.5%) and fewer days of SHSe on average (~11 vs ~12 days), and that intervention versus control condition communities reported greater coalition awareness (24.3% vs 12.2%) and activity exposure (71.2% vs 64.5%). Multivariable modelling indicated that intervention (vs control) communities reported greater rates of complete smoke-free homes (adjusted Odds Ratio [aOR] 1.55, 95% confiedence interval [CI] 1.11 to 2.18, p=0.011) and coalition awareness (aOR 2.89, 95% CI 1.44 to 8.05, p=0.043) at follow-up. However, there were no intervention effects on policy support, SHSe or community-based activity exposure.

conclusionsFindings must be considered alongside several sociopolitical factors during the study, including national smoke-free policies implementation (Georgia, 2018; Armenia, 2022), these countries' participation in an international tobacco legislation initiative, the COVID-19 pandemic and regional/local war). The intervention effect on smoke-free homes is critical, as smoke-free policy implementation provides opportunities to accelerate smoke-free home adoption via local coalitions. TRIAL REGISTRATION NUMBER: NCT03447912.

Indexed as

Tobacco Smoke PollutionArmeniaGeorgiaHumansSurveys and QuestionnairesTobacco Smoke PollutionCluster randomized trialHealth education and promotionHealth policyPublic Health

Identifiers

PMID38325896
PMCPMC10859987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.